We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.44%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$350M
AUM Growth
+$9.81M
(+2.9%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
22.15%
Holding
984
New
159
Increased
201
Reduced
274
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$7.69M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.34M |
| 3 |
abrdn Physical Gold Shares ETF
SGOL
|
+$5.37M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$4.77M |
| 5 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$4.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.86M |
| 2 |
Stellantis
STLA
|
+$5.95M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$5.61M |
| 4 |
iShares MSCI South Africa ETF
EZA
|
+$3.63M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$3.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.27% |
| 2 | Technology | 10.8% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Financials | 9.65% |
| 5 | Materials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Medifast
MED
$108M
| $263K | 0.08% |
1,242
-543
| -30% | -$130K |
|
252
Ambarella
AMBA
$2.99B
| $261K | 0.07% |
2,601
+2,568
| +7,782% | +$280K |
|
253
Eli Lilly
LLY
$1.07T
| $261K | 0.07% |
1,397
-2,653
| -66% | -$519K |
|
254
NeoGenomics
NEO
$1.81B
| $259K | 0.07% |
5,380
-2,273
| -30% | -$118K |
|
255
Veeva Systems
VEEV
$30.3B
| $258K | 0.07% |
988
-909
| -48% | -$253K |
|
|
TRHC
256
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $258K | 0.07% |
5,604
-343
| -6% | -$16.4K |
|
257
ICU Medical
ICUI
$3.93B
| $257K | 0.07% |
1,251
+74
| +6% | +$15.6K |
|
258
Twilio
TWLO
$29.1B
| $257K | 0.07% |
753
+362
| +93% | +$136K |
|
259
Enbridge
ENB
$124B
| $255K | 0.07% |
7,034
-3,500
| -33% | -$123K |
|
260
Chegg
CHGG
$108M
| $255K | 0.07% |
+2,979
| New | +$284K |
|
261
Virgin Galactic
SPCE
$320M
| $255K | 0.07% |
416
+341
| +455% | +$257K |
|
262
Invesco QQQ Trust
QQQ
$455B
| $252K | 0.07% |
791
-23
| -3% | -$7.35K |
|
263
Etsy
ETSY
$7.65B
| $252K | 0.07% |
1,250
-1,230
| -50% | -$257K |
|
264
Axsome Therapeutics
AXSM
$12.4B
| $252K | 0.07% |
4,447
+189
| +4% | +$13.3K |
|
|
VG
265
DELISTED
Vonage Holdings Corporation
VG
| $252K | 0.07% |
21,284
+2,760
| +15% | +$35.9K |
|
266
NovoCure
NVCR
$2.04B
| $250K | 0.07% |
1,890
-819
| -30% | -$130K |
|
267
Snap
SNAP
$7.32B
| $249K | 0.07% |
4,754
+4,753
| +475,300% | +$273K |
|
268
iShares Russell 2000 ETF
IWM
$80.9B
| $245K | 0.07% |
1,109
-490
| -31% | -$107K |
|
|
SWCH
269
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $243K | 0.07% |
14,968
+1,235
| +9% | +$20.6K |
|
270
Intuitive Surgical
ISRG
$121B
| $242K | 0.07% |
984
-762
| -44% | -$192K |
|
271
iShares Russell 1000 Value ETF
IWD
$82B
| $242K | 0.07% |
+1,595
| New | +$231K |
|
272
EnerSys
ENS
$6.95B
| $241K | 0.07% |
2,655
-1,370
| -34% | -$125K |
|
273
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.65B
| $240K | 0.07% |
14,189
-9,510
| -40% | -$159K |
|
274
Revvity
RVTY
$12.3B
| $240K | 0.07% |
1,868
-787
| -30% | -$109K |
|
275
Li Auto
LI
$12.6B
| $239K | 0.07% |
9,572
-4,919
| -34% | -$142K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2021 Portfolio in Review
As of Q1 2021, Exane Derivatives held 984 positions worth $350M, up 2.9% from $340M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Exane Derivatives withdrew a net $17.4M in Q1 2021, closing 107 positions and reducing 274 holdings. Its most notable exit was Amazon, an estimated $6.86M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Linde worth $11.3M.
- Exane Derivatives's largest Q1 2021 buy was Linde: 29,643 shares worth $11.3M.
- Exane Derivatives added most to VanEck Russia ETF in Q1 2021, an estimated $6.34M increase.
- Exane Derivatives's biggest Q1 2021 reduction was Stellantis, cutting an estimated $5.95M.
- Exane Derivatives fully exited Amazon in Q1 2021, selling an estimated $6.86M.
- Exane Derivatives's ten largest holdings make up 22% of its $350M portfolio in Q1 2021.
- Exane Derivatives opened 159 new positions and closed 107 in Q1 2021.
- Exane Derivatives's portfolio value rose 2.9% quarter-over-quarter to $350M.
Based on Exane Derivatives's 13F filing for Q1 2021, filed 30 Apr 2021.